Heart Blocks Treatment Devices Market Growth, Size, Share, Trends, and Forecast 2032

Industry Prospective:

The global heart blocks treatment devices market captured a revenue growth of USD 2.89 billion in 2021 and is forecasted to reach around USD 4.26 billion by 2028, with a compound annual growth rate (CAGR) of approximately 5.9 percent over the forecast period. The report studies the heart blocks treatment devices market’s drivers, restraints, opportunities, challenges, and the effect they have on the product demands throughout the projection period.

Request Free Sample

Global Heart Blocks Treatment Devices Market: Overview

The condition known as heart block causes the heart to beat slower or with an irregular rhythm. It results from an issue with the electrical pulses that regulate the heartbeat. The severity of the heart block will determine the symptoms. First-degree heart block, which could not show any symptoms, is the least threatening. Sometimes, 2nd-degree heart block symptoms might be bothersome and require medical attention. The most serious heart block, which occasionally results in a medical emergency, is the third degree. Pacemakers are among the several devices that may be used to treat heart blockages, they employ electric signals to restore a regular heartbeat.

Request Free Sample

COVID-19 Impact:

The COVID-19 outbreak had a favorable impact on the market for devices to treat heart blockages. The healthcare industry is under significant strain as a result of an increase in coronavirus incidence worldwide. During the pandemic, there has been a sharp increase in heart patients and cardiovascular disorders because these people are more likely to get COVID-19. However, the demand for heart block treatment devices is expected to persist during the projected period owing increasing incidence of cardiac disorders.

Heart Blocks Treatment Devices Market: Growth Drivers

Increasing incidents of cardiac arrest and disease are likely to boost the market growth.

One of the primary contributors to accelerating the growth and demand for heart block treatment devices is the rapidly rising incidence of cardiovascular disease. Additionally, the growing senior population throughout the world is fueling market expansion. Along with the constantly shifting quality of life, the advent of pacemakers and minimally invasive cardiovascular treatments are also contributing to the market’s expansion. In addition, genetic conditions and growing healthcare infrastructure are also contributing to the market expansion. Moreover, the growing prevalence of heart blockage incidents as well as the rising frequency of hypothyroidism, which frequently causes heart blocks are also supporting the demand for heart block treatment devices. The huge aging population and quick technological progress in healthcare facilities will both hasten the growth of the global heart block treatment device market and provide the industry with sizable potential prospects.

Heart Blocks Treatment Devices Market: Restraints

High cost of the devices may hamper the market growth.

Most of the devices involved in the diagnosis and treatment of heart blockages such as ECG, 2D Eco, implantable loop recorder, blockage removal, and catheter for electrophysiology study are costly and require periodic maintenance. However, bearing such high-cost devices is not possible for small clinics and hospitals which restricts the adoption of heart block treatment devices, thereby restricting the market expansion.

Heart Blocks Treatment Devices Market: Opportunities

Rapid expansion of the healthcare sector in emerging countries is projected to offer better growth prospects for market expansion.

The market for devices to treat heart blockages has a lot of promise in emerging nations. Most cardiac disorder treatments require a well-established healthcare infrastructure where the patient can be diagnosed and treated at the same facilities. To provide such facilities many governments are largely investing to strengthen their healthcare infrastructure. In addition, the global heart blocks treatment devices market is anticipated to benefit from rising awareness of heart disorders and improvements in healthcare conditions.

Heart Blocks Treatment Devices Market: Challenges.

Dearth of skilled professionals in healthcare sectors poses a major challenge to the market growth.

The healthcare sector in most developing countries is still in progress and it is vastly dependent on conventional techniques and devices to treat cardiac disorders. One of the prime factors causing such circumstances is low healthcare budget and less involvement & investments by private healthcare operators to operate these devices is further restraining the market growth.

Heart Blocks Treatment Devices Market: Segmentation

The global heart block treatment devices market is categorized based on type, product type, end-user, and region. Based on type, the market is segregated into first-degree heart block, second-degree heart block, and third-degree heart block. Among these types, second-degree heart block dominates the market with more than 45 percent of the share. Second-degree heart block is more common and requires immediate medical attention. Owing to this demand for heart block treatment devices is high in this type. The market is further categorized based on product type into transcutaneous pacing (TCP), mediation, pacemaker, and follow-up electrophysiology study. The end-user segment of the market is divided into hospital testing, clinics, home treatment, and others. The hospital segment dominates the market among other end users with nearly 40 percent of the market share.

Recent Developments:

• In July 2021, to treat patients with heart block in India, Medtronic introduced Micra™ AV, the world's smallest pacemaker incorporating Atrioventricular (AV) Synchrony.
• In June 2020, to track the impact of radiofrequency (RF) energy supply during cardiac ablation treatments, Boston Scientific introduced DirectSense Technology.

Report Scope:

Heart Blocks Treatment Devices Market: Regional Landscape

North America is anticipated to become the most revenue-generating regional market during the forecast period. The region currently holds more than 40 percent of the share in the global heart blocks treatment devices market. This is mainly attributed to its robust R&D efforts, attractive reimbursement systems, accessibility to cutting-edge healthcare technology, and increased patient understanding of newer techniques. Asia Pacific region is expected to have lucrative growth in the foreseeable period. Key factors such as economic growth in emerging nations like China & India, rising patient awareness, and rising healthcare costs associated with heart-related diseases are factors projected to drive the regional market growth. Looking at the stats, the prevalence of heart disease and obesity are increasing at a rapid pace in the region, especially in India. Further, with the increasing uptake of fast food and unhealthy diet, the number of patients suffering from health conditions is predicted to upsurge. This in turn boosts the demand for heart block treatment devices during the forecast period.

Heart Blocks Treatment Devices Market: Competitive Landscape

Major players studied in the report for global heart blocks treatment devices market include Medtronic, Boston Scientific Corporation, MicroPort Scientific Corporation, Abbott, Stryker, Koninklijke Philips N.V., Lepu Medical Technology Co., Ltd., LivaNova PLC, McKesson Corporation, Cigna, SCHILLER, Osypka Medical GmbH, and Shree Pacetronix Ltd.

Global heart blocks treatment devices market is segmented as follows:

By Type

• First-Degree Heart Block
• Second-Degree Heart Block
• Third-Degree Heart Block

By Product Type

• Transcutaneous Pacing (TCP)
• Pacemaker
• Mediation
• Follow-up Electrophysiology Study

By End User

• Hospital Testing
• Home treatment
• Clinics
• Other

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa